Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients

Metabolism: Clinical and Experimental

Volumn 63, Issue 12, 2014, Pages 1542-1552

  Wree, Alexander ^a,b   Schlattjan, Martin ^a   Bechmann, Lars P ^a   Claudel, Thierry ^c   Sowa, Jan Peter ^a   Stojakovic, Tatjana ^d   Scharnagl, Hubert ^d   Köfeler, Harald ^d   Baba, Hideo A ^a   Gerken, Guido ^a   Feldstein, Ariel E ^b   Trauner, Michael ^c   Canbay, Ali ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adipose tissue; Bariatric surgery; Hepatology; Non alcoholic fatty liver disease; Obesity

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN; ARACHIDONIC ACID; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CERVONIC ACID; CLUPANODIC ACID; DIHOMO GAMMA LINOLENIC ACID; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; LACTATE DEHYDROGENASE; LEPTIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; STEARIC ACID; UNCLASSIFIED DRUG; VACCENIC ACID;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; BODY MASS; CELL SIZE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTRIC BANDING; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAABDOMINAL FAT; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SLEEVE GASTRECTOMY; STOMACH BYPASS; WEIGHT REDUCTION; YOUNG ADULT; BLOOD; COHORT ANALYSIS; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADIPOCYTES; ADIPONECTIN; ADULT; APOLIPOPROTEINS; BARIATRIC SURGERY; C-REACTIVE PROTEIN; CELL SIZE; COHORT STUDIES; DISEASE PROGRESSION; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; SEVERITY OF ILLNESS INDEX;

EID: 84908386184     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.09.001     Document Type: Article

References (44)

1. K.M. Flegal, M.D. Carroll, B.K. Kit, and C.L. Ogden Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 JAMA 307 2012 491 497
2. C.L. Ogden, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak, and K.M. Flegal Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
3. M. Lazo, and J.M. Clark The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 2008 339 350
4. S.E. Mahady, and J. George Management of nonalcoholic steatohepatitis: an evidence-based approach Clin Liver Dis 16 2012 631 645
5. L.P. Bechmann, R.A. Hannivoort, G. Gerken, G.S. Hotamisligil, M. Trauner, and A. Canbay The interaction of hepatic lipid and glucose metabolism in liver diseases J Hepatol 56 2012 952 964
6. E. Bugianesi, A.J. McCullough, and G. Marchesini Insulin resistance: a metabolic pathway to chronic liver disease Hepatology 42 2005 987 1000
7. R. Karagozian, Z. Derdak, and G. Baffy Obesity-associated mechanisms of hepatocarcinogenesis Metab Clin Exp 63 2014 607 617
8. B.A. Neuschwander-Tetri Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites Hepatology 52 2010 774 788
9. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
10. L. Sjostrom, K. Narbro, C.D. Sjostrom, K. Karason, B. Larsson, and H. Wedel Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 2007 741 752
11. A. Oberbach, J. Neuhaus, T. Inge, K. Kirsch, N. Schlichting, and S. Bluher Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia Metab Clin Exp 63 2014 242 249
12. M.E. Piche, J. Martin, K. Cianflone, M. Bastien, S. Marceau, and S. Biron Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients Metab Clin Exp 63 2014 79 86
13. A. Kahraman, J.P. Sowa, M. Schlattjan, S. Sydor, M. Pronadl, and A. Wree Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients Clin Sci 125 2013 391 400
14. Gastrointestinal surgery for severe obesity Consensus statement/NIH Consensus Development Conference 9 1991 National Institutes of Health Consensus Development Conference 1 20
15. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
16. E.G. Bligh, and W.J. Dyer A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 1959 911 917
17. C.D. Fuchs, T. Claudel, P. Kumari, G. Haemmerle, M.J. Pollheimer, and T. Stojakovic Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice Hepatology 56 2012 270 280
18. A. Wree, A. Eguchi, M.D. McGeough, C.A. Pena, C.D. Johnson, and A. Canbay NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice Hepatology 59 2014 898 910
19. T. McLaughlin, C. Lamendola, N. Coghlan, T.C. Liu, K. Lerner, and A. Sherman Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fat Obesity 22 2014 673 680
20. J. O'Connell, L. Lynch, T.J. Cawood, A. Kwasnik, N. Nolan, and J. Geoghegan The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity PLoS One 5 2010 e9997
21. M. Jernas, J. Palming, K. Sjoholm, E. Jennische, P.A. Svensson, and B.G. Gabrielsson Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression FASEB J 20 2006 1540 1542
22. T. Skurk, C. Alberti-Huber, C. Herder, and H. Hauner Relationship between adipocyte size and adipokine expression and secretion J Clin Endocrinol Metab 92 2007 1023 1033
23. A. Wree, A. Mayer, S. Westphal, A. Beilfuss, A. Canbay, and R.R. Schick Adipokine expression in brown and white adipocytes in response to hypoxia J Endocrinol Investig 35 2012 522 527
24. J.S. Yudkin, C.D. Stehouwer, J.J. Emeis, and S.W. Coppack C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 1999 972 978
25. D.C. Lau, B. Dhillon, H. Yan, P.E. Szmitko, and S. Verma Adipokines: molecular links between obesity and atheroslcerosis Am J Physiol Heart Circ Physiol 288 2005 H2031 H2041
26. N. Oruc, O. Ozutemiz, G. Yuce, U.S. Akarca, G. Ersoz, and F. Gunsar Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study BMC Gastroenterol 9 2009 16
27. E. Zimmermann, R. Anty, J. Tordjman, A. Verrijken, P. Gual, and A. Tran C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients J Hepatol 55 2011 660 665
28. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
29. J. Tordjman, C. Poitou, D. Hugol, J.L. Bouillot, A. Basdevant, and P. Bedossa Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status J Hepatol 51 2009 354 362
30. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
31. C.S. Gangabadage, J. Zdunek, M. Tessari, S. Nilsson, G. Olivecrona, and S.S. Wijmenga Structure and dynamics of human apolipoprotein CIII J Biol Chem 283 2008 17416 17427
32. A. Kawakami, M. Aikawa, P. Libby, P. Alcaide, F.W. Luscinskas, and F.M. Sacks Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells Circulation 113 2006 691 700
33. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, and X.M. Zhang Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N Engl J Med 362 2010 1082 1089
34. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
35. S.J. Lee, H. Campos, L.A. Moye, and F.M. Sacks LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients Arterioscler Thromb Vasc Biol 23 2003 853 858
36. C.O. Mendivil, E.B. Rimm, J. Furtado, S.E. Chiuve, and F.M. Sacks Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease Circulation 124 2011 2065 2072
37. J. Bolinder, L. Kager, J. Ostman, and P. Arner Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis Diabetes 32 1983 117 123
38. M.F. McCarty Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline Med Hypotheses 52 1999 465 477
39. G.L. Vega, N.B. Cater, D.R. Hadizadeh III, S. Meguro, and S.M. Grundy Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome Clin Pharmacol Ther 74 2003 236 244
40. R.H. Unger Lipid overload and overflow: metabolic trauma and the metabolic syndrome Trends Endocrinol Metab 14 2003 398 403
41. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
42. A. Wree, M.D. McGeough, C.A. Pena, M. Schlattjan, H. Li, and M.E. Inzaugarat NLRP3 inflammasome activation is required for fibrosis development in NAFLD J Mol Med 2014 [Epub ahead of print]
43. P. Mathurin, F. Gonzalez, O. Kerdraon, E. Leteurtre, L. Arnalsteen, and A. Hollebecque The evolution of severe steatosis after bariatric surgery is related to insulin resistance Gastroenterology 130 2006 1617 1624
44. S.G. Mattar, L.M. Velcu, M. Rabinovitz, A.J. Demetris, A.M. Krasinskas, and E. Barinas-Mitchell Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome Ann Surg 242 2005 610 617 [discussion 8-20]